Genotype-phenotype correlations in Darier disease: A focus on the neuropsychiatric phenotype. 2018

Katherine Gordon-Smith, and Elaine Green, and Detelina Grozeva, and Sherine Tavadia, and Nick Craddock, and Lisa Jones
Department of Psychological Medicine, University of Worcester, Worcester, United Kingdom.

Darier disease (DD) is an autosomal dominant skin disorder caused by mutations in ATP2A2 encoding the sarco/endoplasmic reticulum Ca2+ ATPase Isoform 2 (SERCA2). Evidence of a population-level association between DD and psychiatric disorders suggests that mutations in ATP2A2 may have pleiotropic effects on the brain as well as skin. Evidence of genotype-phenotype relationships between ATP2A2 mutations and neuropsychiatric phenotypes would further support this suggestion. We investigated genotype-phenotype correlations between lifetime neuropsychiatric features and ATP2A2 mutation type (dichotomized into likely gene disrupting [LGD] or protein altering) in 75 unrelated individuals with DD. We also looked for evidence of clustering of mutations within SERCA2 according to neuropsychiatric features. Combining our data with the existing literature, the rate of LGD mutations was found to be significantly higher among DD cases/families with bipolar disorder, schizophrenia, or affective psychosis (p = .011). We also found a significant relationship between mutations located in the S4-M4 region of the protein and the presence of a severe neuropsychiatric phenotype (p = .032). Our findings add support to the hypothesis that Darier-causing mutations in ATP2A2 confer susceptibility to neuropsychiatric dysfunction, in particular severe psychiatric illness. This, together with evidence from research on common polymorphisms confirms ATP2A2 as a gene at which variation influences susceptibility to major psychiatric illness.

UI MeSH Term Description Entries
D007644 Darier Disease An autosomal dominantly inherited skin disorder characterized by warty malodorous papules that coalesce into plaques. It is caused by mutations in the ATP2A2 gene encoding SERCA2 protein, one of the SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES. The condition is similar, clinically and histologically, to BENIGN FAMILIAL PEMPHIGUS, another autosomal dominant skin disorder. Both diseases have defective calcium pumps (CALCIUM-TRANSPORTING ATPASES) and unstable desmosomal adhesion junctions (DESMOSOMES) between KERATINOCYTES. Acrokeratosis Verruciformis of Hopf,Darier-White Disease,Keratosis Follicularis,Acantholytic Dyskeratotic Epidermal Nevi,Acantholytic Dyskeratotic Epidermal Nevus,Acrokeratosis Verruciformis,Darier's Disease,Hopf Disease,Darier White Disease,Darier-White Diseases,Dariers Disease,Disease, Darier,Disease, Darier's,Disease, Darier-White,Disease, Hopf,Diseases, Darier-White,Diseases, Hopf,Hopf Acrokeratosis Verruciformis,Hopf Diseases,Verruciformis, Acrokeratosis
D008297 Male Males
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D005260 Female Females
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001523 Mental Disorders Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function. Mental Illness,Psychiatric Diseases,Psychiatric Disorders,Psychiatric Illness,Behavior Disorders,Diagnosis, Psychiatric,Mental Disorders, Severe,Psychiatric Diagnosis,Illness, Mental,Mental Disorder,Mental Disorder, Severe,Mental Illnesses,Psychiatric Disease,Psychiatric Disorder,Psychiatric Illnesses,Severe Mental Disorder,Severe Mental Disorders
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.
D053498 Sarcoplasmic Reticulum Calcium-Transporting ATPases Calcium-transporting ATPases that catalyze the active transport of CALCIUM into the SARCOPLASMIC RETICULUM vesicles from the CYTOPLASM. They are primarily found in MUSCLE CELLS and play a role in the relaxation of MUSCLES. Calcium-Transporting ATPases, Sarcoplasmic Reticulum,Sarcoplasmic Reticulum Calcium ATPase,SERCA Calcium ATPase,SERCA1 Calcium ATPase,SERCA2 Calcium ATPase,SERCA2a Calcium ATPase,SERCA3 Calcium ATPase,SR Ca(2+)-ATPase 1,SR Ca(2+)-ATPase 2,SR Ca(2+)-ATPase 3,Sarco-Endoplasmic Reticulum Ca2+-ATPase,Sarcoplasmic Reticulum Ca(2+)-ATPase,Sarcoplasmic Reticulum Calcium-Transporting ATPase 1,Sarcoplasmic Reticulum Calcium-Transporting ATPase 2,Sarcoplasmic Reticulum Calcium-Transporting ATPase 2a,Sarcoplasmic Reticulum Calcium-Transporting ATPase 3,Sarcoplasmic-Endoplasmic Reticulum Calcium ATPase 2,Sarcoplasmic-Endoplasmic Reticulum Calcium ATPase 2a,Sarcoplasmic-Endoplasmic Reticulum Calcium ATPase 3,Sarcoplasmic-endoplasmic Reticulum Calcium ATPase 1,Ca2+-ATPase, Sarco-Endoplasmic Reticulum,Calcium Transporting ATPases, Sarcoplasmic Reticulum,Reticulum Ca2+-ATPase, Sarco-Endoplasmic,Sarco Endoplasmic Reticulum Ca2+ ATPase,Sarcoplasmic Endoplasmic Reticulum Calcium ATPase 2,Sarcoplasmic Endoplasmic Reticulum Calcium ATPase 2a,Sarcoplasmic Endoplasmic Reticulum Calcium ATPase 3,Sarcoplasmic Reticulum Calcium Transporting ATPase 1,Sarcoplasmic Reticulum Calcium Transporting ATPase 2,Sarcoplasmic Reticulum Calcium Transporting ATPase 2a,Sarcoplasmic Reticulum Calcium Transporting ATPase 3,Sarcoplasmic Reticulum Calcium Transporting ATPases,Sarcoplasmic endoplasmic Reticulum Calcium ATPase 1

Related Publications

Katherine Gordon-Smith, and Elaine Green, and Detelina Grozeva, and Sherine Tavadia, and Nick Craddock, and Lisa Jones
September 2010, The British journal of dermatology,
Katherine Gordon-Smith, and Elaine Green, and Detelina Grozeva, and Sherine Tavadia, and Nick Craddock, and Lisa Jones
June 2021, Clinical case reports,
Katherine Gordon-Smith, and Elaine Green, and Detelina Grozeva, and Sherine Tavadia, and Nick Craddock, and Lisa Jones
January 2020, Frontiers in endocrinology,
Katherine Gordon-Smith, and Elaine Green, and Detelina Grozeva, and Sherine Tavadia, and Nick Craddock, and Lisa Jones
October 1995, Lancet (London, England),
Katherine Gordon-Smith, and Elaine Green, and Detelina Grozeva, and Sherine Tavadia, and Nick Craddock, and Lisa Jones
February 2001, Experimental dermatology,
Katherine Gordon-Smith, and Elaine Green, and Detelina Grozeva, and Sherine Tavadia, and Nick Craddock, and Lisa Jones
July 2007, Gastroenterology & hepatology,
Katherine Gordon-Smith, and Elaine Green, and Detelina Grozeva, and Sherine Tavadia, and Nick Craddock, and Lisa Jones
August 2015, Journal of the European Academy of Dermatology and Venereology : JEADV,
Katherine Gordon-Smith, and Elaine Green, and Detelina Grozeva, and Sherine Tavadia, and Nick Craddock, and Lisa Jones
January 2017, International review of neurobiology,
Katherine Gordon-Smith, and Elaine Green, and Detelina Grozeva, and Sherine Tavadia, and Nick Craddock, and Lisa Jones
June 1998, Journal of internal medicine,
Katherine Gordon-Smith, and Elaine Green, and Detelina Grozeva, and Sherine Tavadia, and Nick Craddock, and Lisa Jones
February 2007, Human mutation,
Copied contents to your clipboard!